Vai al contenuto principale della pagina
| Autore: |
Kwaan Hau C
|
| Titolo: |
The Role of Fibrinolytic System in Health and Disease
|
| Pubblicazione: | Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022 |
| Descrizione fisica: | 1 online resource (170 p.) |
| Soggetto topico: | Biology, life sciences |
| Research & information: general | |
| Soggetto non controllato: | acute lung injury and repair and pleural injury and pleural organization |
| aging | |
| antiplasmin | |
| brown adipose tissue | |
| cancer | |
| carboxypeptidase | |
| cardiovascular disease | |
| clot retraction | |
| clot stability | |
| coagulation | |
| COVID-19 | |
| Factor XIII | |
| fibrinolysis | |
| fibrosis | |
| immune response | |
| inflammation | |
| NETs | |
| neurodegeneration | |
| obesity | |
| obstructive sleep apnoea | |
| OSA | |
| PA system | |
| PAI-1 | |
| PAI-2 | |
| plasmin | |
| plasminogen activation | |
| plasminogen activator | |
| plasminogen activator inhibitor 1 (PAI-1) | |
| plasminogen activator inhibitor-1 | |
| platelets | |
| proCPB | |
| proCPR | |
| proCPU | |
| renin-aldosterone-angiotensin-system (RAAS) | |
| shear | |
| TAFI | |
| thrombin | |
| thrombin activatable fibrinolysis inhibitor | |
| tissue-type plasminogen activator (tPA) | |
| uPA | |
| uPAR | |
| urokinase plasminogen activator | |
| urokinase plasminogen activator receptor | |
| urokinase-type plasminogen activator (uPA) | |
| Persona (resp. second.): | KwaanHau C |
| Sommario/riassunto: | This is a review of the topic of fibrinolysis contributed by authors who are specialized in the clinical and basic studies of this topic. These include: the endothelial receptor of tissue plasminogen activator, by Dr. Katherine Hajjar; regulation of S100 by pml-rar-alpha oncoprotein, by Dr. O'Connell; receptor of urokinase type plasminogen activator, by Dr. M. Ploug et al.; tissue plasminogen activator induction in purjinjen neuron, by Dr. Seeds; fibrinolysis from the blood to the brain, by Dr. Robert Metcalf; tissue plasminogen activator induces the opening of the blood-brain barrier, by Dr. M. Yepes; fibrinolysis shutdown in trauma: a historical review and clinical application, by Drs. Hunter Moore and Ernest Moore; fibrinolysis in immunity, by Drs. K. Kolev and Robert Medcalf; the role of plasminogen activator inhibitor 1, by Drs. M. Erin, A.E. Boe, and E.A. Klyachko; and finally, persistent fibrinolysis shutdown is associated with increased mortality in severely injured trauma patients, by J.P. Meizoso. |
| Titolo autorizzato: | The Role of Fibrinolytic System in Health and Disease ![]() |
| Formato: | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910580213103321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |